PolmoniAMO_INGL

30 18. Lugo A, et al. Smoking in Italy 2013-2014, with a focus on the young. Tumori [Tumours] 2015;101:529-34. 19. https://www.epicentro.iss.it/passi/dati/fumo 20. GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388(10053):1659-724. 21. Carter, A.J., Nguyen, C.N. A comparison of cancer burden and research spending reveals discrepancies in the distri- bution of research funding. BMC Public Health 2012;12:526. 22. Begum M, et al. Research on lung cancer and its funding, 2004-2018. ecancer 2020;14(1132):1-13. 23. Chapple A, et al. Stigma, shame, and blame experienced by patients with lung cancer: qualitative study. BMJ 2004; 328:1470. 24. Novellis P, et al. Lung cancer screening: who pays? Who receives? The European perspectives. Transl Lung Cancer Res 2021;10(5):2395-2406. 25. Henschke CI, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999;354:99-105. 26. Diederich S, et al. Screening for early lung cancer with low-dose spiral computed tomography: results of annual fol- low-up examinations in asymptomatic smokers. Eur Radiol 2004;14:691-702. 27. Sone S, et al. Characteristics of small lung cancers invisible on conventional chest radiography and detected by pop- ulation based screening using spiral CT. Br J Radiol 2000;73:137-45. 28. Swensen SJ, et al. Lung cancer screening with CT: Mayo Clinic experience. Radiology 2003;226:756-61. 29. Pelosi G, et al. Pathologic and molecular features of screening low-dose computed tomography (LDCT)-detected lung cancer: a baseline and 2-year repeat study. Lung Cancer 2008;62:202-14. 30. Mulshine JL, Sullivan DC. Clinical practice. Lung cancer screening. N Engl J Med 2005;352:2714-20. 31. Veronesi G, et al. Lung cancer screening with low-dose computed tomography: a noninvasive diagnostic protocol for baseline lung nodules. Lung Cancer 2008;61:340-9. 32. Veronesi G, et al. Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program. J Thorac Cardiovasc Surg 2008;136:611-7. 33. van Klaveren RJ, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009;361:2221-9. 34. Aberle DR, et al. Reduced lung cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409. 35. Moyer VA, on behalf of the USPSTF. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine 2014;160(5):330-8. 36. Crosbie PA, et al. Implementing lung cancer screening: baseline results from a community-based ‘Lung Health Check’ pilot in deprived areas of Manchester. Thorax 2019;74(4):405-9. 37. Passiglia F, Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis. J Clin Oncol 2021;39:2574-85.   38. de Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced lung-cancer mortality with volume CT screening in a ran- domized trial. N Engl J Med 2020;382:503-13. 39. Pastorino U, Rossi M, Rosato V et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev 2012;21(3):308-15. 40. Pastorino U, et al. Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening. Eur J Cancer 2019;118:142-8. 41. Pastorino U. Tumore al polmone: lo screening può salvare la vita dei fumatori In Tredicesimo Rapporto sulla condizione assistenziale dei malati oncologici. [Lung cancer: screening can save the lives of smokers, In the Thirteenth Report on the condition of cancer patients.] Available from: https://osservatorio.favo.it/tredicesimo-rapporto/. Last accessed 10 February 2022.